For more than 40 years, Genentech has been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, Genentech makes medicines to treat patients with serious medical conditions. Genentech is headquartered in South San Francisco, California.

Bayer is dedicated to providing treatment options for people living with rare, serious and life-threatening disease. Bayer has been a committed partner to the community delivering therapeutic options, educational and support programs and continuing research designed to meet the needs of patients throughout their life journey.

CSL Behring is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and neurological disorders. The company’s products are also used in cardiac surgery, burn treatment and to prevent hemolytic disease of the newborn. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. For inspiring stories about the promise of biotechnology, visit Vita CSLBehring.com/vita and follow us on Twitter.com/CSLBehring.

Spark Therapeutics is creating a path for advancements in hemophilia gene therapy research. We are committed to discovering, developing and delivering gene therapies, we challenge the inevitability of genetic diseases.

Our commitment to helping patients and their physicians manage complex drug therapies by delivering expert individualized care and unmatched, multi-channel access has made us one of the leading specialty pharmacies in the country. We provide a full-range of pharmaceutical care, dispensing the latest FDA-approved medications.

Nuestro compromiso de ayudar a los pacientes y a sus médicos a administrar terapias farmacológicas complejas al brindar atención individualizada experta y acceso multicanal sin igual nos ha convertido en una de las farmacias especializadas líderes en el país. Ofrecemos una gama completa de atención farmacéutica, distribuyendo los últimos medicamentos aprobados por la FDA.

For 30 years, Novo Nordisk has been a driving force for people living with rare bleeding disorders. We take pride in striving for innovative solutions to help improve patients’ lives. This motivates us to uphold the highest standards in our product research and development. This vital research is just the beginning of our commitment in hemophilia. We’ll continue our research and connect with people with hemophilia and healthcare professionals to ensure we understand and respond to specific needs of the hemophilia community. We’ll continue to develop innovative solutions that can help improve the lives of people with hemophilia in the future.

BioMarin is a world leader in developing and commercializing innovative therapies for rare diseases driven by genetic causes. Visit www.biomarin.com to learn more.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

Interested in learning more about Takeda’s current products and resources? Follow the link below.